Oberweis Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$364K Buy
1,036
+1
+0.1% +$356 0.01% 163
2025
Q4
$339K Buy
1,035
+1
+0.1% +$317 0.01% 170
2025
Q3
$292K Hold
1,034
0.01% 176
2025
Q2
$289K Buy
1,034
+1
+0.1% +$283 0.01% 178
2025
Q1
$322K Buy
1,033
+1
+0.1% +$295 0.02% 183
2024
Q4
$269K Buy
1,032
+1
+0.1% +$297 0.01% 190
2024
Q3
$332K Sell
1,031
-40
-4% -$13.1K 0.02% 197
2024
Q2
$335K Buy
1,071
+1
+0.1% +$294 0.02% 186
2024
Q1
$304K Buy
1,070
+1
+0.1% +$293 0.02% 185
2023
Q4
$308K Sell
1,069
-155
-13% -$42.2K 0.03% 185
2023
Q3
$329K Sell
1,224
-159
-11% -$39.7K 0.03% 182
2023
Q2
$307K Buy
1,383
+1
+0.1% +$232 0.04% 171
2023
Q1
$334K Buy
1,382
+1
+0.1% +$245 0.05% 159
2022
Q4
$363K Buy
1,381
+1
+0.1% +$268 0.08% 153
2022
Q3
$311K Buy
1,380
+1
+0.1% +$242 0.07% 159
2022
Q2
$336K Hold
1,379
0.09% 136
2022
Q1
$333K Buy
1,379
+1
+0.1% +$230 0.07% 130
2021
Q4
$310K Sell
1,378
-119
-8% -$25.1K 0.06% 132
2021
Q3
$318K Buy
1,497
+1
+0.1% +$230 0.07% 127
2021
Q2
$365K Buy
1,496
+1
+0.1% +$246 0.08% 115
2021
Q1
$372K Buy
1,495
+1
+0.1% +$239 0.08% 124
2020
Q4
$344K Buy
1,494
+1
+0.1% +$231 0.09% 108
2020
Q3
$380K Hold
1,493
0.13% 93
2020
Q2
$352K Sell
1,493
-19
-1% -$4.33K 0.14% 101
2020
Q1
$307K Buy
1,512
+1
+0.1% +$218 0.17% 128
2019
Q4
$364K Buy
1,511
+1
+0.1% +$220 0.12% 157
2019
Q3
$292K Sell
1,510
-72
-5% -$13.8K 0.07% 170
2019
Q2
$292K Buy
1,582
+1
+0.1% +$179 0.05% 171
2019
Q1
$300K Buy
1,581
+2
+0.1% +$382 0.06% 166
2018
Q4
$307K Buy
1,579
+3
+0.2% +$585 0.07% 171
2018
Q3
$327K Sell
1,576
-1
-0.1% -$197 0.06% 180
2018
Q2
$291K Sell
1,577
-72
-4% -$12.7K 0.07% 198
2018
Q1
$281K Hold
1,649
0.07% 203
2017
Q4
$287K Sell
1,649
-247
-13% -$43.7K 0.07% 210
2017
Q3
$354K Sell
1,896
-131
-6% -$23.2K 0.1% 129
2017
Q2
$349K Sell
2,027
-300
-13% -$48.8K 0.1% 119
2017
Q1
$382K Sell
2,327
-28
-1% -$4.65K 0.11% 109
2016
Q4
$344K Sell
2,355
-1
-0% -$151 0.1% 109
2016
Q3
$393K Sell
2,356
-127
-5% -$21.5K 0.11% 104
2016
Q2
$378K Sell
2,483
-151
-6% -$23.5K 0.11% 127
2016
Q1
$395K Buy
2,634
+103
+4% +$15.3K 0.11% 133
2015
Q4
$411K Sell
2,531
-1
-0% -$157 0.12% 139
2015
Q3
$350K Buy
2,532
+1
+0% +$158 0.1% 120
2015
Q2
$389K Sell
2,531
-358
-12% -$57.3K 0.1% 120
2015
Q1
$462K Hold
2,889
0.13% 99
2014
Q4
$460K Sell
2,889
-41
-1% -$6.39K 0.14% 84
2014
Q3
$412K Sell
2,930
-39
-1% -$5.09K 0.11% 91
2014
Q2
$351K Buy
2,969
+102
+4% +$11.8K 0.09% 113
2014
Q1
$354K Hold
2,867
0.07% 120
2013
Q4
$327K Buy
2,867
+96
+3% +$10.9K 0.08% 116
2013
Q3
$310K Sell
2,771
-250
-8% -$27.1K 0.09% 104
2013
Q2
$298K Buy
+3,021
New +$313K 0.08% 127

Other funds holding AMGN

Oberweis Asset Management's AMGN Position: Q1 2026 in Review

Oberweis Asset Management increased its Amgen (AMGN) stake by 0.1% in Q1 2026, buying an estimated $356 and bringing the position to 1,036 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #163.

Oberweis Asset Management first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $462K in Q1 2015. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Oberweis Asset Management held 1,036 shares of Amgen worth $364K as of Q1 2026.
  • Oberweis Asset Management bought 1 Amgen share in Q1 2026, an estimated $356.
  • Amgen made up 0.01% of Oberweis Asset Management's portfolio in Q1 2026, its #163 holding.
  • Oberweis Asset Management first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Oberweis Asset Management's Amgen position peaked at $462K in Q1 2015.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Oberweis Asset Management's 13F filing for Q1 2026, filed 15 May 2026.